(Q42687643)

4 November 2017

title

Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a (English)

1 reference

Markus Peck-Radosavljevic

4 November 2017

author

5

object named as

Markus Peck-Radosavljevic

0 references

author name string

Harald Hofer

1

1 reference

4 November 2017

Hans C Bankl

2

1 reference

4 November 2017

Friedrich Wrba

3

1 reference

4 November 2017

Petra Steindl-Munda

4

1 reference

4 November 2017

Christoph Osterreicher

6

1 reference

4 November 2017

Christian Mueller

7

1 reference

4 November 2017

Alfred Gangl

8

1 reference

4 November 2017

Peter Ferenci

9

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

The American Journal of Gastroenterology

4 November 2017

published in

1 reference

4 November 2017

volume

97

1 reference

4 November 2017

issue

11

1 reference

4 November 2017

page(s)

2880-2885

1 reference

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Iron overload in patients with chronic hepatitis C: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07056.X

10.1111/J.1572-0241.2002.07056.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference